Advertisement
Screener

VSee Health, Inc. (VSEE) Graph

VSEE Revenue Flow

Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.

  • 2021-03-31: Net income $0.00.

Product or service

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

VSEE revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Health CarePatient Service$601.09KInstitutional Fees$0.00Telehealth Fees$960.79KRevenue$1.56MCost of revenue$1.36MGross profit$206.15KOperating expenses$2.90MOperating income-$2.70MOther income, net$0.00Pre-tax income-$3.10MIncome tax-$17.90K

Timing Of Transfer Of Good Or Service

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

VSEE revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Transferred AtPoint In Time$1.56MTransferred Over Time$0.00Revenue$1.56MCost of revenue$1.36MGross profit$206.15KOperating expenses$2.90MOperating income-$2.70MOther income, net$0.00Pre-tax income-$3.10MIncome tax-$17.90K

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 1 month

Period endNet income
2021-03-31$0.00

Revenue and expense 3 month

Period endRevenueCost of revenueOperating expensesIncome taxNet income
2026-06-30$1.56M$1.36M$2.90M-$17.90K(m)
2026-03-31$3.16M$1.96M$4.17M$23.74K-$2.60M
2025-12-31$3.93M*$2.09M*$5.27M*(m)-$7.85M*
2025-09-30$3.98M$1.91M$4.13M$0.00-$289.75K
2025-06-30$1.06M$440.15K$2.17M$1.73K-$2.61M
2025-03-31$3.32M$1.46M$3.69M$13.51K-$3.96M
2024-09-30$3.35M$569.73K$61.08M$8.80K-$53.92M
2024-06-30$1.71M$934.57K$1.71M-$1.68M-$634.12K
2024-03-31$1.62M$386.25K$1.13M$0.00$62.77K
2023-09-30$1.43M$478.40K$1.31M-$233.72K-$189.76K
2023-06-30$1.27M$474.29K$1.49M-$174.40K-$503.32K
2023-03-31$1.58M(m)$1.72M(m)-$529.96K
2022-09-30(m)(m)(m)$83.03K-$820.76K
2022-06-30(m)(m)(m)$0.00-$659.46K
2022-03-31(m)(m)(m)(m)-$527.36K
2021-09-30(m)(m)(m)(m)-$180.00
2021-06-30(m)(m)(m)(m)-$5.00K

Revenue and expense 4 month

Period endNet income
2021-06-30-$5.00K

Revenue and expense 6 month

Period endRevenueCost of revenueOperating expensesIncome taxNet income
2026-06-30$3.44M$2.51M$5.29M$5.26K-$4.34M
2025-06-30$2.25M$827.52K$4.53M$15.23K-$5.54M
2024-06-30$3.33M$1.32M$2.84M-$1.68M-$571.35K
2023-06-30$2.85M$1.05M$3.21M-$357.24K-$1.03M
2022-06-30(m)(m)(m)$0.00-$1.19M

Revenue and expense 7 month

Period endNet income
2021-09-30-$5.18K

Revenue and expense 9 month

Period endRevenueCost of revenueOperating expensesIncome taxNet income
2025-09-30$10.69M$5.17M$11.67M$17.99K-$6.86M
2024-09-30$6.69M$1.89M$63.92M-$1.67M-$54.49M
2023-09-30$4.28M$1.53M$4.51M-$590.95K-$1.22M
2022-09-30(m)(m)(m)$83.03K-$2.01M
2021-12-31(m)(m)(m)(m)-$280.70K

Revenue and expense 12 month

Period endRevenueCost of revenueOperating expensesIncome taxNet income
2025-12-31$14.62M$7.26M$16.94M$13.51K-$14.71M
2024-12-31$10.42M$3.24M$69.33M-$1.64M-$57.70M
2023-12-31$5.77M$1.93M$5.71M$1.84M-$3.76M
2022-12-31(m)(m)(m)$187.22K-$3.24M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Agape ATP Corp (ATPC)$0.002B
DocGo Inc. (DCGO)United States$0.034B-0.25
Strata Critical Medical, Inc. (SRTA)United States$0.467B11.33
InnovAge Holding Corp. (INNV)United States$1.206B-635.60
Omada Health, Inc. (OMDA)United States$1.207B309.08
U S PHYSICAL THERAPY INC /NV (USPH)United States$1.251B32.48
Pennant Group, Inc. (PNTG)United States$1.386B39.84
Privia Health Group, Inc. (PRVA)United States$2.477B115.52
GeneDx Holdings Corp. (WGS)United States$2.638B-19.23
LifeStance Health Group, Inc. (LFST)United States$4.510B80.86